The European Investment Bank (EIB), through its development arm – EIB Global, is investing $37.5 million in Alta Semper Fund II to support the growth of pharmaceutical and healthcare companies across Africa, including medical equipment and technologies. Targeting primarily North Africa (around 70%) and, to a lesser extent, sub-Saharan Africa (about 30%), the fund will strengthen innovation and sustainability in the life sciences sector while deepening EU-Africa trade relations.